McNicol A M, Kubba M A, Stewart C J
University Department of Pathology, Royal Infirmary, Glasgow, U.K.
J Pathol. 1988 Feb;154(2):181-6. doi: 10.1002/path.1711540211.
Adult Sprague-Dawley rats received a daily intraperitoneal injection of dexamethasone (100 or 200 micrograms/kg) for 2 or 6 weeks. Quantitative assessment of the anterior pituitary corticotroph population performed using the stereological measurement of volume density (Vv). An indirect assessment of corticotroph function was also made, based on adrenal weight and histology. Adrenal changes were consistent with dose-related inhibition of corticotroph function in all dexamethasone-treated animals. Immunopositive corticotrophs were easily identified and in no treatment group was corticotroph Vv significantly less than in the appropriate vehicle-injected control group. In male animals, there was a significant increase (P less than 0.05) in Vv with 100 micrograms/kg at both 2 and 6 weeks. These results suggest that it is possible to produce inhibition of corticotroph function by the administration of such doses of dexamethasone without causing a significant reduction in the anterior pituitary corticotroph population. This may be related to the mode of negative feedback of such a regime.
成年Sprague-Dawley大鼠每日腹腔注射地塞米松(100或200微克/千克),持续2周或6周。使用体积密度(Vv)的体视学测量对垂体前叶促肾上腺皮质激素细胞群体进行定量评估。还基于肾上腺重量和组织学对促肾上腺皮质激素细胞功能进行了间接评估。在所有接受地塞米松治疗的动物中,肾上腺变化与促肾上腺皮质激素细胞功能的剂量相关抑制一致。免疫阳性促肾上腺皮质激素细胞易于识别,且在任何治疗组中,促肾上腺皮质激素细胞的Vv均未显著低于相应的注射赋形剂对照组。在雄性动物中,在2周和6周时,100微克/千克剂量组的Vv均显著增加(P<0.05)。这些结果表明,给予此类剂量的地塞米松有可能抑制促肾上腺皮质激素细胞功能,而不会导致垂体前叶促肾上腺皮质激素细胞数量显著减少。这可能与此类给药方案的负反馈模式有关。